Benjamin F. Synoground, Yogender Gowtham, Timothy Lindquist, Junessa Pressley, Derrick C. Scott, Christopher S. Saski, Sarah W. Harcum
{"title":"Transcriptomic Insights Into Serum-Free Medium Adaptation and Temperature Reduction in Chinese Hamster Ovary Cell Cultures","authors":"Benjamin F. Synoground, Yogender Gowtham, Timothy Lindquist, Junessa Pressley, Derrick C. Scott, Christopher S. Saski, Sarah W. Harcum","doi":"10.1002/biot.70055","DOIUrl":null,"url":null,"abstract":"<p>Chinese hamster ovary (CHO) cells are widely used in recombinant biopharmaceutical production; yet, yields remain low, leading to high market prices. Improving product yield and quality has heavily relied on empirical characterization with limited insight into internal molecular dynamics. RNA-seq offers a powerful alternative to understand intracellular responses to process changes through gene expression measurement. In this study, three RNA-seq datasets across three CHO cell lines and four industrially relevant treatments were integrated to characterize the global transcriptome changes, construct a weighted gene co-expression network, assess the impact on recombinant anti-interleukin 8 (anti-IL8) immunoglobulin heavy and light chain transcript abundance, and expression of glycosylation genes. Treatments included adaptation to serum-free medium, low temperature, low pH, and low glucose concentration in the medium. The findings suggest upregulation of cholesterol biosynthesis is critical for serum-free medium adaptation, and the rate-limiting enzymes in the sterol regulatory element-binding protein pathway (<i>Insig1</i> and <i>Srebf2</i>) could be targeted to accelerate adaptation. Temperature-induced cell cycle suppression was likely mediated by p53 activation, consistent with previous reports, with the p53-targets, <i>Zmat3</i> and <i>Btg2</i>, identified as key hub genes. Conversely, glucose and pH were observed to have negligible impacts on the transcriptome. This study uniquely identifies novel genes mediating temperature-induced cell cycle arrest, distinct glycosylation-related gene responses impacting product quality, and new stable housekeeping genes for accurate gene expression normalization in CHO cells.</p>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 7","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/biot.70055","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70055","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Chinese hamster ovary (CHO) cells are widely used in recombinant biopharmaceutical production; yet, yields remain low, leading to high market prices. Improving product yield and quality has heavily relied on empirical characterization with limited insight into internal molecular dynamics. RNA-seq offers a powerful alternative to understand intracellular responses to process changes through gene expression measurement. In this study, three RNA-seq datasets across three CHO cell lines and four industrially relevant treatments were integrated to characterize the global transcriptome changes, construct a weighted gene co-expression network, assess the impact on recombinant anti-interleukin 8 (anti-IL8) immunoglobulin heavy and light chain transcript abundance, and expression of glycosylation genes. Treatments included adaptation to serum-free medium, low temperature, low pH, and low glucose concentration in the medium. The findings suggest upregulation of cholesterol biosynthesis is critical for serum-free medium adaptation, and the rate-limiting enzymes in the sterol regulatory element-binding protein pathway (Insig1 and Srebf2) could be targeted to accelerate adaptation. Temperature-induced cell cycle suppression was likely mediated by p53 activation, consistent with previous reports, with the p53-targets, Zmat3 and Btg2, identified as key hub genes. Conversely, glucose and pH were observed to have negligible impacts on the transcriptome. This study uniquely identifies novel genes mediating temperature-induced cell cycle arrest, distinct glycosylation-related gene responses impacting product quality, and new stable housekeeping genes for accurate gene expression normalization in CHO cells.
中国仓鼠卵巢(CHO)细胞广泛应用于重组生物制药生产;然而,收益率仍然很低,导致市场价格居高不下。提高产品收率和质量在很大程度上依赖于对内部分子动力学的有限见解的经验表征。RNA-seq提供了一个强大的替代了解细胞内的反应过程变化通过基因表达测量。本研究整合了三种CHO细胞系和四种工业相关处理的三个RNA-seq数据集,以表征全局转录组变化,构建加权基因共表达网络,评估对重组抗白细胞间素8 (anti- il - 8)免疫球蛋白重链和轻链转录物丰度以及糖基化基因表达的影响。处理包括适应无血清培养基、低温、低pH和培养基中的低葡萄糖浓度。研究结果表明,胆固醇生物合成的上调对于无血清培养基的适应至关重要,并且可以靶向固醇调节元件结合蛋白途径中的限速酶(Insig1和Srebf2)来加速适应。温度诱导的细胞周期抑制可能是由p53激活介导的,与先前的报道一致,p53靶点Zmat3和Btg2被确定为关键枢纽基因。相反,葡萄糖和pH值对转录组的影响可以忽略不计。该研究独特地鉴定了介导温度诱导的细胞周期阻滞的新基因,影响产品质量的独特糖基化相关基因反应,以及CHO细胞中精确基因表达正常化的新稳定管家基因。
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.